Journal profile · OPHTHALMOLOGY
Clinical Ophthalmology
ISSN 1177-5483 · Dove Medical Press · United Kingdom
Clinical Ophthalmology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5 (journal website); JCR Q2 (journal website); fully open access; APC about USD 3,940; median 86 days to acceptance (138 articles, last 24 months); acceptance rate 43% (journal website); 478 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Clinical Ophthalmology is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Ophthalmology and Visual Impairment Studies and Corneal surgery and disorders, together about 33.3% of its articles. Its main subfields are Ophthalmology and Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Dr Sotiria Palioura Clinical Ophthalmology is an international, open access, peer-reviewed journal covering all subspecialties within ophthalmology, including ophthalmic clinical practice, visual science, and innovations in surgical techniques. The journal’s audience includes ophthalmologists, optometrists, orthoptists, and researchers interested in advancing eye care, visual science, and patient outcomes. The journal has a special interest in topics such as pharmacology and drug therapy in eye diseases, patient safety and quality of care improvements, and eye health promotion. Authors are invited to submit their work to dedicated sections of the journal, including cataract, retina, and general ophthalmology. Authors are required to provide imaging and diagnostic studies regarding their clinical findings. Basic science studies, such as cell biology and genetics studies, must have direct clinical relevance. Additionally, the journal does not accept pure, non-human animal studies or case reports/series, which are to be redirected to the International Medical Case Reports Journal. The journal welcomes for consideration the following article types: original research, reviews, editorials, commentaries, clinical trial reports, and protocols. All articles received by the journal will be subject to single anonymous peer review. When considering submission of a paper utilizing publicly available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample. All meta-analyses require a pre-submission check prior to submitting to Clinical Ophthalmology. Please complete the pre-submission check form here. Updated 7 January 2026
From the journal's Aims & Scope
Research area (LetPub): OPHTHALMOLOGY
Editor-in-chief Sotiria PaliouraPublisher website
Editorial board by country: 3 in mainland China (about 4%); most named United States 23, United Kingdom 6, Italy 6, India 4, Mainland China 3 (73 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine12.9%
- Ophthalmology and Visual Impairment StudiesMedicine10.2%
- Corneal surgery and disordersMedicine10.2%
- Retinal Diseases and TreatmentsMedicine9.8%
- Intraocular Surgery and LensesMedicine9.8%
- Retinal and Macular SurgeryMedicine8.2%
- Ocular Surface and Contact LensMedicine6.5%
- Corneal Surgery and TreatmentsMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.5Publisher website ·
- 5-year impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 1.19Publisher website ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 1.19LetPub ·
- h-index
- 103OpenAlex ·
- i10-index
- 3,162OpenAlex ·
- 2-year mean citedness
- 2.2OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 99.34%LetPub ·
Volume
- Articles per year
- 453LetPub ·
- Downloads per year (publisher)
- 620,620Publisher website ·
Articles by year OpenAlex count · 7,870 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 469 | 469 | 93 |
| 2025 | 478 | 478 | 952 |
| 2024 | 431 | 431 | 1,993 |
| 2023 | 407 | 407 | 3,710 |
| 2022 | 424 | 424 | 4,530 |
| 2021 | 572 | 572 | 6,912 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
86 daysMedian, submission to acceptance · P25–P75 64 days – 114 days
- Acceptance to online
- median 20 days (138 articles)
- Submission to online
- median 110 days
- Sample
- 138 articles with submission and acceptance dates (1,068 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 43%Publisher website ·
- Desk decision
- 51 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePlagiarism
- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1177-5483
- Print ISSN
- 1177-5467
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical Ophthalmology
What CAS zone is Clinical Ophthalmology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Ophthalmology is in Zone 4 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Ophthalmology?
The journal's website gives an impact factor of 2.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4, h-index 103.
How long does peer review take at Clinical Ophthalmology?
Based on the dates recorded on 138 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 64–114 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 43%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Clinical Ophthalmology in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Clinical Ophthalmology based?
Of the 73 board members whose country the journal's board page names, 3 (about 4%) are in mainland China; the countries named most often are United States (23), United Kingdom (6) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Ophthalmology?
According to LetPub and DOAJ records, Clinical Ophthalmology is indexed in ESCI, Scopus and DOAJ.
Is Clinical Ophthalmology open access, and what is the APC?
Clinical Ophthalmology is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .